Literature DB >> 15327834

Sequence variation in the I-like domain of the beta1 integrin subunit in human oral squamous cell carcinomas.

Richard D Evans1, Judith Jones, Claire Taylor, Fiona M Watt.   

Abstract

We recently identified a heterozygous mutation in the beta1 integrin subunit of a squamous cell carcinoma (SCC) that maps to the I-like domain and activates ligand binding. To investigate the frequency of such mutations we screened 124 human oral SCCs. We identified six single nucleotide changes, all of which were also present in normal tissue, suggestive of polymorphisms. Two were in non-coding intronic sequences. Three were silent changes in exons. One caused a change in amino acid (A239V) that is unlikely to disturb integrin structure. We conclude that mutations in the beta1 I-like domain are uncommon in SCCs. However, population based studies of the polymorphisms we found may reveal an association with SCC development or prognosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327834     DOI: 10.1016/j.canlet.2004.05.013

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

Review 1.  Cell-extracellular matrix interactions in normal and diseased skin.

Authors:  Fiona M Watt; Hironobu Fujiwara
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-04-01       Impact factor: 10.005

2.  Genetic ablation of alphav integrins in epithelial cells of the eyelid skin and conjunctiva leads to squamous cell carcinoma.

Authors:  Joseph H McCarty; Marc Barry; Denise Crowley; Roderick T Bronson; Adam Lacy-Hulbert; Richard O Hynes
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

3.  An activating beta1 integrin mutation increases the conversion of benign to malignant skin tumors.

Authors:  Manuela Ferreira; Hironobu Fujiwara; Kazumasa Morita; Fiona M Watt
Journal:  Cancer Res       Date:  2009-02-03       Impact factor: 12.701

4.  Loss of the α2β1 integrin alters human papilloma virus-induced squamous carcinoma progression in vivo and in vitro.

Authors:  Thuy Tran; Brittney Barlow; Lynda O'Rear; Brenda Jarvis; Zhengzhi Li; Kent Dickeson; William Dupont; Mary Zutter
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.